Schedule 13G ownership disclosure

LYRA THERAPEUTICS INC

Security class unavailable · CUSIP: 55234L105

Event date: 2023-11-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,000,000
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-23-005625
Form type
SC 13G
Filer
Lyra Therapeutics, Inc.
CIK
CIK 1327273
Filed
Nov 16, 2023
Reporting period
Nov 15, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub